Search

Your search keyword '"Ipilimumab -- Patient outcomes"' showing total 1 results
Start Over Descriptor "Ipilimumab -- Patient outcomes" Journal urology times
1 results on '"Ipilimumab -- Patient outcomes"'

1. Data from mUC combination therapy suggest efficacy, safety

Subjects
Ipilimumab -- Patient outcomes, Urologic cancer -- Drug therapy, Nivolumab -- Patient outcomes, Combination drug therapy -- Methods -- Patient outcomes, Business, Health care industry
Abstract

Bristol-Myers Squibb recently presented data from its phase I/II open-label CheckMate-032 trial investigating two combination schedules of nivolumab (Opdivo) plus ipilimumab (Yervoy) in patients with metastatic urothelial carcinoma (mUC). The [...]

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results